COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers’ Perceptions

(1) Background: During 2019, the COVID-19 pandemic was threatening healthcare services and workers, and acquiring immunity was an option to stop or limit the burden of this pandemic. Herd immunity was a top priority worldwide as the virus was spreading rapidly. It was estimated that 67% of the total global population should be immunized against COVID-19 to achieve herd immunity. The aim of the current study is to investigate different perceptions of healthcare workers in the Kingdom of Bahrain and Egypt using an online survey in an attempt to evaluate their awareness and concerns regarding new variants and booster doses. (2) Methods: This study conducted a survey on healthcare workers in the Kingdom of Bahrain and Egypt about their perception and concerns on the COVID-19 vaccines. (3) Results: The study found that out of 389 healthcare workers 46.1% of the physicians were not willing to take the booster doses (p = 0.004). Physicians also did not support taking the COVID-19 vaccine as an annual vaccine (p = 0.04). Furthermore, to assess the association between the type of vaccine taken with the willingness of taking a booster vaccine, healthcare workers beliefs on vaccine effectiveness (p = 0.001), suspension or contact with patients (p = 0.000), and infection after COVID-19 vaccination (p = 0.016) were significant. (4) Conclusion: Knowledge about vaccine accreditation and regulation should be dispersed more widely to ensure that the population has a positive perception on vaccine safety and effectiveness

Seroprevalence and epidemiology of Toxoplasma gondii in farm animals in different regions of Egypt

application/pdfToxoplasmosis is a cosmopolitan protozoan disease that has been recorded in a wide range of vertebrate hosts, including humans. In response to the paucity of available data, this study was undertaken to comprehensively establish the seroprevalence of Toxoplasma gondii among various farm animals in different localities of Egypt. The latex agglutination test and TgGRA7-based enzyme-linked immunosorbent assay were used to screen the investigated animals for anti-T. gondii IgG antibodies. When only samples with simultaneously positive results for both the latex agglutination test and the TgGRA7-based ELISA were considered positive, 174 (26.7%) of 652 serum samples from different animals were seropositive. The prevalence of antibodies according to species was: sheep 38.7%, goats 28.7%, cattle 23.6%, and donkeys 22.6%. Thus, prevalence rate was significantly higher in sheep than in cattle or donkeys. The prevalence was also significantly higher in Kafr El Sheikh than in the other governorates investigated (Qena, Sohag, Minoufiya, and Matrouh). No significant differences were observed in age, sex, locality, or breeding system when evaluated as predisposing factors for T. gondii infection in cattle. In conclusion, this study demonstrates the high prevalence for T. gondii-specific antibodies among different animal species in southern and northern localities of Egypt, and provides valuable new data on the prevalence of T. gondii in donkeys, which are used as a food for carnivorous animals, particularly in the feline family, at Giza Zoo, Egypt